PL195000A1 - Sposob wytwarzania n-/4-/2-(pirazolo-1-karbonamido)-etylo/-benzenosulfonylo/-mocznikow - Google Patents
Sposob wytwarzania n-/4-/2-(pirazolo-1-karbonamido)-etylo/-benzenosulfonylo/-mocznikowInfo
- Publication number
- PL195000A1 PL195000A1 PL19500076A PL19500076A PL195000A1 PL 195000 A1 PL195000 A1 PL 195000A1 PL 19500076 A PL19500076 A PL 19500076A PL 19500076 A PL19500076 A PL 19500076A PL 195000 A1 PL195000 A1 PL 195000A1
- Authority
- PL
- Poland
- Prior art keywords
- benzensulfonylo
- carbonamido
- pyrazolo
- ureas
- ethyl
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/16—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL1976195000A PL106114B1 (pl) | 1976-12-31 | 1976-12-31 | Sposob wytwarzania nowych n-(4-/2-/pirazolo-1-karbonamido/-etylo/-benzenosulfonylo)-mocznikow |
| SU772552354A SU789520A1 (ru) | 1976-12-31 | 1977-12-13 | Способ получени -/4-/2-(пиразол-1-карбонамид)-этил/бензолсульфонил/ мочевин |
| US05/862,755 US4153710A (en) | 1976-12-31 | 1977-12-20 | N-(4-[2-(pyrazole-1-carbonamide)-ethyl]-benzenesulphonyl)-urea |
| GB53313/77A GB1592380A (en) | 1976-12-31 | 1977-12-21 | Pharmacologically-active benzenesulphonyl urea derivatives and pharmaceutical compositions thereof |
| JP16094077A JPS53149974A (en) | 1976-12-31 | 1977-12-28 | Nn*44*22pyrazolee1111*arbonamide** ethyl**benzenesulfonyl*urea process for preparing same and medical composition containing same |
| DE772759241A DE2759241C3 (de) | 1976-12-31 | 1977-12-31 | N-(4-(2-(pyrazol-1-carbonamido)-athyl)-benzolsulfonyl) carbonide, verfahren zu ihrer herstellung und arzneimittel |
| SU782688156A SU816398A3 (ru) | 1976-12-31 | 1978-11-24 | Способ получени - 4-/2-(пиразол-1-КАРбОНАМид)-эТил/-бЕНзОлСульфОНил-МОчЕВиН |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL1976195000A PL106114B1 (pl) | 1976-12-31 | 1976-12-31 | Sposob wytwarzania nowych n-(4-/2-/pirazolo-1-karbonamido/-etylo/-benzenosulfonylo)-mocznikow |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL195000A1 true PL195000A1 (pl) | 1978-11-20 |
| PL106114B1 PL106114B1 (pl) | 1979-11-30 |
Family
ID=19980256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1976195000A PL106114B1 (pl) | 1976-12-31 | 1976-12-31 | Sposob wytwarzania nowych n-(4-/2-/pirazolo-1-karbonamido/-etylo/-benzenosulfonylo)-mocznikow |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US4153710A (pl) |
| JP (1) | JPS53149974A (pl) |
| DE (1) | DE2759241C3 (pl) |
| GB (1) | GB1592380A (pl) |
| PL (1) | PL106114B1 (pl) |
| SU (2) | SU789520A1 (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL370989A1 (pl) * | 2001-12-21 | 2005-06-13 | Novo Nordisk A/S | Pochodne amidowe jako aktywatory GK |
| AU2003243921B2 (en) * | 2002-06-27 | 2009-05-07 | Novo Nordisk A/S | Aryl carbonyl derivatives as therapeutic agents |
| BRPI0506662B8 (pt) * | 2004-01-06 | 2021-05-25 | Novo Nordisk As | compostos ativadores de glucoquinase |
| JP2009500377A (ja) * | 2005-07-08 | 2009-01-08 | ノボ・ノルデイスク・エー／エス | ジシクロアルキルウレア型グルコキナーゼ活性化剤 |
| EP1904438B1 (en) * | 2005-07-08 | 2012-02-29 | Novo Nordisk A/S | Dicycloalkylcarbamoyl ureas as glucokinase activators |
| EP1904467B1 (en) | 2005-07-14 | 2013-05-01 | Novo Nordisk A/S | Urea glucokinase activators |
| EP2118083A1 (en) * | 2007-01-09 | 2009-11-18 | Novo Nordisk A/S | Urea glucokinase activators |
| JP5226008B2 (ja) | 2007-01-11 | 2013-07-03 | ノボ・ノルデイスク・エー／エス | ウレアグルコキナーゼアクチベーター |
| CN112040945A (zh) | 2018-06-12 | 2020-12-04 | Vtv治疗有限责任公司 | 葡萄糖激酶激活剂与胰岛素或胰岛素类似物组合的治疗用途 |
| US12391658B2 (en) | 2020-02-18 | 2025-08-19 | Vtv Therapeutics Llc | Sulfoxide and sulfone glucokinase activators and methods of use thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH516578A (de) * | 1967-11-02 | 1971-12-15 | Bayer Ag | Verfahren zur Herstellung von heterocyclische Acylaminogruppen enthaltenden Arylsulfonylharnstoffen mit blutdrucksenkender Wirkung |
| US3668215A (en) * | 1967-11-25 | 1972-06-06 | Bayer Ag | Aryl-sulphonyl-semicarbazides containing heterocyclic acylamino groups |
| US3887709A (en) * | 1971-09-16 | 1975-06-03 | Zdzislaw Brzozowski | 2-Pyrazoline-1-carboxamide sulfonamide derivatives useful as hypoglycemic agents |
| CH593263A5 (pl) * | 1974-02-22 | 1977-11-30 | Hoffmann La Roche | |
| US4007201A (en) * | 1975-05-30 | 1977-02-08 | Kyorin Pharmaceutical Co. Ltd. | Novel pyrazole derivatives |
-
1976
- 1976-12-31 PL PL1976195000A patent/PL106114B1/pl unknown
-
1977
- 1977-12-13 SU SU772552354A patent/SU789520A1/ru active
- 1977-12-20 US US05/862,755 patent/US4153710A/en not_active Expired - Lifetime
- 1977-12-21 GB GB53313/77A patent/GB1592380A/en not_active Expired
- 1977-12-28 JP JP16094077A patent/JPS53149974A/ja active Granted
- 1977-12-31 DE DE772759241A patent/DE2759241C3/de not_active Expired
-
1978
- 1978-11-24 SU SU782688156A patent/SU816398A3/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5633391B2 (pl) | 1981-08-03 |
| PL106114B1 (pl) | 1979-11-30 |
| SU816398A3 (ru) | 1981-03-23 |
| US4153710A (en) | 1979-05-08 |
| GB1592380A (en) | 1981-07-08 |
| JPS53149974A (en) | 1978-12-27 |
| DE2759241A1 (de) | 1978-07-06 |
| DE2759241B2 (de) | 1980-07-24 |
| DE2759241C3 (de) | 1981-05-21 |
| SU789520A1 (ru) | 1980-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL201586A1 (pl) | Sposob wytwarzania nowych zwiazkow spiro-hydantionowych | |
| PL196505A1 (pl) | Sposob wytwarzania nowych zwiazkow aminoalkiloheterocyklicznych | |
| PL201286A1 (pl) | Sposob wytwarzania nowych 1-aryloksy-2-hydroksy-3-alkileno-aminopropanow | |
| PL200289A1 (pl) | Sposob wytwarzania zwiazkow 3-chlorocefemowych | |
| PL195000A1 (pl) | Sposob wytwarzania n-/4-/2-(pirazolo-1-karbonamido)-etylo/-benzenosulfonylo/-mocznikow | |
| PL200534A1 (pl) | Sposob wytwarzania nowych oksadeztiacefalosporyn | |
| PL200583A1 (pl) | Sposob wytwarzania nowych pochodnych benzopiranu | |
| PL211409A1 (pl) | Sposob wytwarzania nowych podstawionych pirolidyn | |
| PL200605A1 (pl) | Sposob wytwarzania nowych pochodnych metioninoenkefaliny | |
| PL208543A1 (pl) | Sposob wytwarzania nowych imidazoizochinolinodionow | |
| PL192659A1 (pl) | Sposob wytwarzania nowych dwufenyloamin | |
| PL198874A1 (pl) | Sposob wytwarzania pewnych 2-(4-podstawionych piperazynylo-1)-4-aminochinazolin | |
| PL199602A1 (pl) | Sposob otrzymywania nowych pochodnych kwasu pirolokarboksylowego-1 | |
| PL104866B1 (pl) | Sposob wytwarzania nowych pirydobenzodwuazepinonow | |
| PL209050A1 (pl) | Sposob wytwarzania aldehydow | |
| PL202660A1 (pl) | Sposob wytwarzania nowych pochodnych spirooksazolidynodionu | |
| PL207928A1 (pl) | Sposob wytwarzania n-/4-/2-(pirazolo-1-karbonamido)-etylo/-benzenosulfonylo/-mocznikow | |
| PL201161A1 (pl) | Sposob wytwarzania nowych pochodnych 9-chloroprednisolonu | |
| PL196061A1 (pl) | Sposob wytwarzania nowych pochodnych indolizyny | |
| PL197311A1 (pl) | Sposob wytwarzania nowych zwiazkow ketotia | |
| PL201883A1 (pl) | Sposob wytwarzania nowych pochodnych trans-5a-arylo-dziesieciowodorobenzazepiny | |
| PL190443A1 (pl) | Sposob otrzymywania p-nitrodwufenyloaminy | |
| PL196543A1 (pl) | Sposob wytwarzania nowych pochodnych azyrydyny | |
| PL198980A1 (pl) | Sposob wytwarzania nowych pochodnych n-/2-pirazolino-1-karbonimidoilo-/guanidyny | |
| PL193263A1 (pl) | Sposob wytwarzania nowych trzeciorzedowych dwufenyloamin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RECP | Rectifications of patent specification |